TERN - Terns Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$55.56
DETAILS
HIGH:
$70.00
LOW:
$35.00
MEDIAN:
$56.00
CONSENSUS:
$55.56
UPSIDE:
4.93%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 62.41 |
| Quick Ratio | 62.41 |
| Solvency Ratio | -5.185 |
| Cash Ratio | 31.98 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-39.12
Peers avg: 13.6
|
| PEG Ratio | 4.87 |
| Forward PEG | 4.87 |
| Price/Book | 3.74 |
| Price/Sales | 0.00 |
| Price/FCF | -45.80 |
| Price/Op Cash Flow | -45.80 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0009 |
| Debt/Equity | 0.0009 |
| Debt/Capital | 0.0009 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.02 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -5.007 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -89.42 |
| Capital Expenditure Coverage | 0.00 |
| Dividend + Capital Expenditure Coverage | 0.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -1.033 |
| Debt/Share | 0.0099 |
| Cash/Share | 10.94 |
| Book Value/Share | 10.80 |
| Tangible BV/Share | 10.80 |
| Equity/Share | 10.80 |
| Operating Cash Flow/Share | -0.882 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -0.882 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.006 |
| Earnings Before Tax/EBIT | 0.868 |
| Price/Fair Value | 3.74 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | -0.6% |
| Enterprise Value Multiple | -29.42 |